A phase 1/2, open-label, dose-escalation study of midostaurin in children with relapsed or refractory acute leukaemia

C.M. Zwaan, S. Söderhäll, B. Brethon, M. Luciani, C. Rizzari, R.W. Stam, E. Besse, C. Dutreix, F. Fagioli, P.A. Ho, C. Dufour, R. Pieters

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)623-627
Number of pages5
JournalBritish Journal of Haematology
Issue number3
Publication statusPublished - 2019

Cite this